Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 15.

Notter, T; Coughlin, J M; Gschwind, T; Weber-Stadlbauer, U; Wang, Y; Kassiou, M; Vernon, A C; Benke, D; Pomper, M G; Sawa, A; Meyer, U (2018). Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Molecular Psychiatry, 23(2):323-334.

Benke, D; Balakrishnan, Karthik; Zemoura, Khaled (2016). Molecular organization, trafficking, and degradation of the GABA-B receptor. In: Colombo, Giancarlo. GABA-B Receptor. Cham, Switzerland: Humana Press, 55-74.

Zeilhofer, H U; Benke, D; Yévenes, G E (2012). Chronic pain states: Pharmacological strategies to restore diminished inhibitory spinal pain control. Annual Review of Pharmacology and Toxicology, 52(1):111-133.

Panzanelli, P; Gunn, B G; Schlatter, M C; Benke, D; Tyagarajan, S K; Scheiffele, P; Belelli, D; Lambert, J J; Rudolph, U; Fritschy, J M (2011). Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells. Journal of Physiology, 589(Pt 20):4959-4980.

Di Lio, A; Benke, D; Besson, M; Desmeules, J; Daali, Y; Wang, Z J; Edwankar, R; Cook, J M; Zeilhofer, H U (2011). HZ166, a novel GABA(A) receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain. Neuropharmacology, 60(4):626-632.

Maier, Patrick J; Marin, I; Grampp, T; Sommer, A; Benke, D (2010). Sustained glutamate receptor activation downregulates GABA(B) receptors by shifting the balance from recycling to lysosomal degradation. Journal of Biological Chemistry, 285(46):35606-35614.

Benke, D (2010). Mechanisms of GABAB receptor exocytosis, endocytosis, and degradation. Advances in Pharmacology, 58:93-111.

Balic, E; Rudolph, U; Fritschy, J M; Mohler, H; Benke, D (2009). The alpha5(H105R) mutation impairs alpha5 selective binding properties by altered positioning of the alpha5 subunit in GABAA receptors containing two distinct types of alpha subunits. Journal of Neurochemistry, 110(1):244-254.

Singer, P; Yee, B K; Feldon, J; Iwasato, T; Itohara, S; Grampp, T; Prenosil, G; Benke, D; Möhler, H; Boison, D (2009). Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1. Neuroscience, 161(2):635-654.

Benke, D; Barberis, A; Kopp, S; Altmann, K H; Schubiger, M; Vogt, K E; Rudolph, U; Möhler, H (2009). GABA(A) receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology, 56(1):174-181.

Benke, D. Molecular architecture, distribution and trafficking of neuronal GABA-B receptors. 2009, University of Zurich, Faculty of Medicine.

Grampp, T; Notz, V; Broll, I; Fischer, N; Benke, D (2008). Constitutive, agonist-accelerated, recycling and lysosomal degradation of GABA(B) receptors in cortical neurons. Molecular and Cellular Neuroscience, 39(4):628-637.

Yee, B K; Balic, E; Singer, P; Schwerdel, C; Grampp, T; Gabernet, L; Knuesel, I; Benke, D; Feldon, J; Mohler, H; Boison, D (2006). Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. Journal of Neuroscience, 26(12):3169-3181.

Benke, D; Fakitsas, P; Roggenmoser, C; Michel, C; Rudolph, U; Mohler, H (2004). Analysis of the presence and abundance of GABAA receptors containing two different types of alpha subunits in murine brain using point-mutated alpha subunits. Journal of Biological Chemistry, 279(42):43654-43660.

Gao, B; Hagenbuch, B; Kullak-Ublick, G A; Benke, D; Aguzzi, A; Meier, P J (2000). Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. Journal of Pharmacology and Experimental Therapeutics, 249(1):73-79.

This list was generated on Tue Jun 18 11:50:22 2019 CEST.